HealthEquity, Inc. (HQY) Stock Analysis
Range Bound setup
Healthcare · Health Information Services
Hold if already holding. Not a fresh buy at $81.41, but acceptable to hold if already in. Reasons: Negative momentum; Below 200-MA, MA slope -3.4%/30d (confirmed downtrend).
HealthEquity is the largest HSA provider by account count, administering 10.6 million HSAs with $36.5B in assets and 7.2M complementary CDBs as of January 31, 2026. Revenue comes from service fees, custodial fees from insurance company partners and Depository Partners (48% of... Read more
Hold if already holding. Not a fresh buy at $81.41, but acceptable to hold if already in. Reasons: Negative momentum; Below 200-MA, MA slope -3.4%/30d (confirmed downtrend). Chart setup: RSI 55 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Score 5.9/10, moderate confidence.
Passes 6/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 32d clear, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMProductcustodial revenue from insurance company partners and Depository Partners48%10-K Item 1A: 'fees we earn from our insurance company partners and Depository Partners which comprised approximately 48%, 45%, and 39% of our revenues during the fiscal years ended January 31, 2026, 2025, and 2024'
Material Events(8-K, last 90d)
- 2026-04-06Item 5.02MEDIUMCTO Eli Rosner terminated without cause, effective April 17, 2026. Sunil Rajasekar (EVP, Chief Product & Strategy Officer since Jan 2026) to oversee technology organization. No separate CTO successor named.SEC filing →
- 2026-03-30Item 5.02LOWWilliam Gassen (CEO of Sanford Health) appointed to Board, effective immediately. Board expanded from 9 to 10 members. Will serve on Audit and Risk Committee and TCCC.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $81.41, but acceptable to hold if already in. Reasons: Negative momentum; Below 200-MA, MA slope -3.4%/30d (confirmed downtrend). Chart setup: RSI 55 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Target $101.59 (+24.8%), stop $76.41 (−6.5%), A.R:R 3.2:1. Score 5.9/10, moderate confidence.
Take-profit target: $101.59 (+23.6% upside). Target $101.59 (+24.8%), stop $76.41 (−6.5%), A.R:R 3.2:1. Stop-loss: $76.41.
Negative momentum; Below 200-MA, MA slope -3.4%/30d (confirmed downtrend).
HealthEquity, Inc. trades at a P/E of 33.3 (forward 15.4). TrendMatrix value score: 6.1/10. Verdict: Hold.
20 analysts cover HQY with a consensus score of 4.2/5. Average price target: $113.
What does HealthEquity, Inc. do?HealthEquity is the largest HSA provider by account count, administering 10.6 million HSAs with $36.5B in assets and...
HealthEquity is the largest HSA provider by account count, administering 10.6 million HSAs with $36.5B in assets and 7.2M complementary CDBs as of January 31, 2026. Revenue comes from service fees, custodial fees from insurance company partners and Depository Partners (48% of FY2026 revenue), and interchange fees (15%).